| Symbol |
Name |
|
ADCY2
|
adenylate cyclase 2 (brain)
|
|
ADD1
|
adducin 1 (alpha)
|
|
AGER
|
advanced glycosylation end product-specific receptor
|
|
AKT1
|
v-akt murine thymoma viral oncogene homolog 1
|
|
AQP2
|
aquaporin 2 (collecting duct)
|
|
ATF2
|
activating transcription factor 2
|
|
BAD
|
BCL2-associated agonist of cell death
|
|
CAMK2A
|
calcium/calmodulin-dependent protein kinase II alpha
|
|
CASP9
|
caspase 9, apoptosis-related cysteine peptidase
|
|
CCND1
|
cyclin D1
|
|
CREM
|
cAMP responsive element modulator
|
|
DAB2
|
Dab, mitogen-responsive phosphoprotein, homolog 2 (Drosophila)
|
|
DPYSL2
|
dihydropyrimidinase-like 2
|
|
DPYSL3
|
dihydropyrimidinase-like 3
|
|
DRD2
|
dopamine receptor D2
|
|
EGFR
|
epidermal growth factor receptor
|
|
EIF4EBP1
|
eukaryotic translation initiation factor 4E binding protein 1
|
|
ELK1
|
ELK1, member of ETS oncogene family
|
|
ESR1
|
estrogen receptor 1
|
|
FSCN1
|
fascin actin-bundling protein 1
|
|
GJA1
|
gap junction protein, alpha 1, 43kDa
|
|
GRIA2
|
glutamate receptor, ionotropic, AMPA 2
|
|
GSK3A
|
glycogen synthase kinase 3 alpha
|
|
GSK3B
|
glycogen synthase kinase 3 beta
|
|
H3F3A
|
H3 histone, family 3A
|
|
H3F3B
|
H3 histone, family 3B (H3.3B)
|
|
HBEGF
|
heparin-binding EGF-like growth factor
|
|
HIST1H3A
|
histone cluster 1, H3a
|
|
HMGN1
|
high mobility group nucleosome binding domain 1
|
|
HMGN2
|
high mobility group nucleosomal binding domain 2
|
|
HNRNPD
|
heterogeneous nuclear ribonucleoprotein D (AU-rich element RNA binding protein 1, 37kDa)
|
|
IKBKB
|
inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase beta
|
|
IL2RA
|
interleukin 2 receptor, alpha
|
|
ILF3
|
interleukin enhancer binding factor 3, 90kDa
|
|
INPPL1
|
inositol polyphosphate phosphatase-like 1
|
|
JUN
|
jun proto-oncogene
|
|
LRP1
|
low density lipoprotein receptor-related protein 1
|
|
MAP2K1
|
mitogen-activated protein kinase kinase 1
|
|
MAP2K2
|
mitogen-activated protein kinase kinase 2
|
|
MAPK1
|
mitogen-activated protein kinase 1
|
|
MAPK3
|
mitogen-activated protein kinase 3
|
|
MAPK8
|
mitogen-activated protein kinase 8
|
|
MAPK9
|
mitogen-activated protein kinase 9
|
|
MCL1
|
myeloid cell leukemia 1
|
|
MOK
|
MOK protein kinase
|
|
MYCL
|
v-myc avian myelocytomatosis viral oncogene lung carcinoma derived homolog
|
|
MYL12B
|
myosin, light chain 12B, regulatory
|
|
NFE2L2
|
nuclear factor, erythroid 2-like 2
|
|
NFKBIA
|
nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha
|
|
NR4A1
|
nuclear receptor subfamily 4, group A, member 1
|
|
PEA15
|
phosphoprotein enriched in astrocytes 15
|
|
PLA2G4A
|
phospholipase A2, group IVA (cytosolic, calcium-dependent)
|
|
PLCB1
|
phospholipase C, beta 1 (phosphoinositide-specific)
|
|
PPARG
|
peroxisome proliferator-activated receptor gamma
|
|
PPP1R12A
|
protein phosphatase 1, regulatory subunit 12A
|
|
PRKCA
|
protein kinase C, alpha
|
|
PTPN1
|
protein tyrosine phosphatase, non-receptor type 1
|
|
PTPN11
|
protein tyrosine phosphatase, non-receptor type 11
|
|
PTPN12
|
protein tyrosine phosphatase, non-receptor type 12
|
|
PTPRA
|
protein tyrosine phosphatase, receptor type, A
|
|
PXN
|
paxillin
|
|
RAF1
|
Raf-1 proto-oncogene, serine/threonine kinase
|
|
RELA
|
v-rel avian reticuloendotheliosis viral oncogene homolog A
|
|
RPS6KA1
|
ribosomal protein S6 kinase, 90kDa, polypeptide 1
|
|
RPS6KA3
|
ribosomal protein S6 kinase, 90kDa, polypeptide 3
|
|
RPS6KA5
|
ribosomal protein S6 kinase, 90kDa, polypeptide 5
|
|
SHC1
|
SHC (Src homology 2 domain containing) transforming protein 1
|
|
SLC6A12
|
solute carrier family 6 (neurotransmitter transporter), member 12
|
|
SRC
|
SRC proto-oncogene, non-receptor tyrosine kinase
|
|
SRF
|
serum response factor (c-fos serum response element-binding transcription factor)
|
|
STAT1
|
signal transducer and activator of transcription 1, 91kDa
|
|
THOC5
|
THO complex 5
|
|
TP53
|
tumor protein p53
|
|
VDR
|
vitamin D (1,25- dihydroxyvitamin D3) receptor
|
|
VTN
|
vitronectin
|
